These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16271760)

  • 21. Mutations of the PU.1 Ets domain are specifically associated with murine radiation-induced, but not human therapy-related, acute myeloid leukaemia.
    Suraweera N; Meijne E; Moody J; Carvajal-Carmona LG; Yoshida K; Pollard P; Fitzgibbon J; Riches A; van Laar T; Huiskamp R; Rowan A; Tomlinson IP; Silver A
    Oncogene; 2005 May; 24(22):3678-83. PubMed ID: 15750630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KIT and FLT3 receptor tyrosine kinase mutations in acute myeloid leukemia with favorable cytogenetics: two novel mutations and selective occurrence in leukemia subtypes and age groups.
    Sritana N; Auewarakul CU
    Exp Mol Pathol; 2008 Dec; 85(3):227-31. PubMed ID: 18977345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dap12 expression in activated microglia from retinoschisin-deficient retina and its PU.1-dependent promoter regulation.
    Weigelt K; Ernst W; Walczak Y; Ebert S; Loenhardt T; Klug M; Rehli M; Weber BH; Langmann T
    J Leukoc Biol; 2007 Dec; 82(6):1564-74. PubMed ID: 17827340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia.
    Burda P; Vargova J; Curik N; Salek C; Papadopoulos GL; Strouboulis J; Stopka T
    PLoS One; 2016; 11(3):e0152234. PubMed ID: 27010793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncogenic Flt3 receptors display different specificity and kinetics of autophosphorylation.
    Razumovskaya E; Masson K; Khan R; Bengtsson S; Rönnstrand L
    Exp Hematol; 2009 Aug; 37(8):979-89. PubMed ID: 19477218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukemogenesis in heterozygous PU.1 knockout mice.
    Genik PC; Vyazunova I; Steffen LS; Bacher JW; Bielefeldt-Ohmann H; McKercher S; Ullrich RL; Fallgren CM; Weil MM; Ray FA
    Radiat Res; 2014 Sep; 182(3):310-5. PubMed ID: 25076114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia.
    Colovic N; Tosic N; Aveic S; Djuric M; Milic N; Bumbasirevic V; Colovic M; Pavlovic S
    Ann Hematol; 2007 Oct; 86(10):741-7. PubMed ID: 17579862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kras mutations and PU.1 promoter methylation are new pathways in murine radiation-induced AML.
    O'Brien G; Cruz-Garcia L; Zyla J; Brown N; Finnon R; Polanska J; Badie C
    Carcinogenesis; 2020 Aug; 41(8):1104-1112. PubMed ID: 31646336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
    Mueller BU; Pabst T; Fos J; Petkovic V; Fey MF; Asou N; Buergi U; Tenen DG
    Blood; 2006 Apr; 107(8):3330-8. PubMed ID: 16352814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling.
    Al Shaer L; Walsby E; Gilkes A; Tonks A; Walsh V; Mills K; Burnett A; Rowntree C
    Br J Haematol; 2008 May; 141(4):483-93. PubMed ID: 18373709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1.
    Rosenbauer F; Owens BM; Yu L; Tumang JR; Steidl U; Kutok JL; Clayton LK; Wagner K; Scheller M; Iwasaki H; Liu C; Hackanson B; Akashi K; Leutz A; Rothstein TL; Plass C; Tenen DG
    Nat Genet; 2006 Jan; 38(1):27-37. PubMed ID: 16311598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sfpi1/PU.1 mutations in mouse radiation-induced acute myeloid leukaemias affect mRNA and protein abundance and associate with disrupted transcription.
    Brown NL; Finnon R; Bulman RA; Finnon P; Moody J; Bouffler SD; Badie C
    Leuk Res; 2011 Jan; 35(1):126-32. PubMed ID: 20638124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The actin-binding protein CORO1A is a novel PU.1 (SPI1)- and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patients.
    Federzoni EA; Humbert M; Valk PJ; Behre G; Leibundgut EO; Torbett BE; Fey MF; Tschan MP
    Br J Haematol; 2013 Mar; 160(6):855-9. PubMed ID: 23252456
    [No Abstract]   [Full Text] [Related]  

  • 34. Aberrant expression of CD7 in acute myeloid leukemias with FLT3-ITD.
    Juncà J; Zamora L; Cabezón M; Marcè S; Nomdedéu J
    Am J Clin Pathol; 2008 Oct; 130(4):644; author reply 645. PubMed ID: 18825844
    [No Abstract]   [Full Text] [Related]  

  • 35. FLT3/ITD expression increases expansion, survival and entry into cell cycle of human haematopoietic stem/progenitor cells.
    Li L; Piloto O; Kim KT; Ye Z; Nguyen HB; Yu X; Levis M; Cheng L; Small D
    Br J Haematol; 2007 Apr; 137(1):64-75. PubMed ID: 17359372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATRA can enhance apoptosis that is induced by Flt3 tyrosine kinase inhibition in Flt3-ITD positive cells.
    Scholl S; Müller R; Clement JH; Loncarevic IF; Böhmer FD; Höffken K
    Leuk Res; 2006 May; 30(5):633-42. PubMed ID: 16473406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-DR-negative AML (M1 and M2): FLT3 mutations (ITD and D835) and cell-surface antigen expression.
    Syampurnawati M; Tatsumi E; Furuta K; Takenokuchi M; Nakamachi Y; Kawano S; Kumagai S; Saigo K; Matsui T; Takahashi T; Nagai K; Yabe H; Kondo S; Hayashi Y
    Leuk Res; 2007 Jul; 31(7):921-9. PubMed ID: 17056111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of foetal-like tyrosine kinase 3 mutation in Egyptian children with acute leukaemia.
    Al-Tonbary Y; Mansour AK; Ghazy H; Elghannam DM; Abd-Elghaffar HA
    Int J Lab Hematol; 2009 Jun; 31(3):320-6. PubMed ID: 18336585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C/EBPα and MYB regulate FLT3 expression in AML.
    Volpe G; Walton DS; Del Pozzo W; Garcia P; Dassé E; O'Neill LP; Griffiths M; Frampton J; Dumon S
    Leukemia; 2013 Jul; 27(7):1487-96. PubMed ID: 23340802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance and detection of the internal tandem duplication of the FLT3 gene in acute myeloid leukemia.
    Gagyi E; Horváth E; Bödör C; Timár B; Matolcsy A; Pávai Z
    Rom J Morphol Embryol; 2006; 47(4):331-7. PubMed ID: 17392978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.